A: Calculated value by the data on the sample and the calibration curve (pg/tube) R: Recovery (%) V: Taken volume of a sample solution (ml).
The detection limits were 0.2ng/ml for 24,25(OH)2D2 and 24,25(OH)2D3, and 8pg/ml for 1,25(OH)2D2 and 1,25(OH)2D3, respectively. The ND (not detected) means that the values were below the respective lower limits.
Assay of vitamin D and its metabolites in urine. Exactly 50ml of a urine sample was taken and lyophilized, saponified with alkali, and the unsaponifiable matter was extracted according to the conventional method, which was applied to the assay of vitamin D and its metabolites in the plasma.
Biochemical measurements. Biochemical measurements were performed by Nichiyaku Medical Laboratories Co. (Japan) according to the conventional methods. RESULTS 
Medical examinations for volunteers
The medical examinations described in the EXPERIMENTAL section were per formed three times-before, during, and after the experiments-in the eight volunteers including the two who were enrolled in a preliminary experiment. All data showed that all of them were healthy, and neither hypervitaminosis nor hypovitaminosis was observed in the volunteers.
Results on the preliminary experiment
A preliminary experiment on experiment 1 (repeated administration of 400IU of vitamin D2 per day through a multivitamin tablet for 1 week) was performed on the volunteers according to the EXPERIMENTAL section, and the changes in the plas ma concentrations of vitamin D and its metabolites are shown in Table 1 . When the concentrations of vitamin D and its metabolites in the urine during 24h at the 7th day were also assayed on the two volunteers, neither vitamin D (D2 and D3) nor the metabolites was detected in the urine of volunteers. Therefore, we decided that the collection of urine samples would not be performed in experiments 1 and 2.
Results on experiment 1
Experiment 1 (daily administration of 400IU of vitamin D2 by a multivitamin tablet for 1 week) was performed on the six volunteers according to the protocol. Since one of the six volunteers showed abnormally high values of 1,25(OH)2D2 and 1,25(OH)2D3 in the plasma levels at the all stages after administration, all the data on this volunteer were excluded from the statistical analysis. The results on the remaining five volunteers are shown in Figs. 1 and 2 , which stress mainly the daily and hourly variations of the plasma levels, respectively.
Results on experiment 2
Experiment 2 (single administration of 0.25ml of a vitamin D liquid prepara tion equivalent to 4,000IU of vitamin D2) was performed in the three volunteers according to the protocol. The hourly variations in the plasma levels of vitamin D2 F VITAMIN D2 261 transported and metabolized to 25-OH-D3 in the liver. It has been reported that the major circulating metabolite of vitamin D3 is 25-OH-D3 and its plasma con centration directly reflects the nutritional status of vitamin D, especially en dogenous vitamin D3 (1). The levels of 25-OH-D3 gave fairly constant values between 25 and 33ng/ml. Since experiment 1 was carried out in the winter season to avoid the seasonal variation and the subjects were instructed to conduct a usual life, relatively constant levels within the normal range (10-40ng/ml) were obtained. Therefore, the data suggested that this vitamin D3 is normally photosynthesized in the skin with appropriate exposure to sunlight. It is well documented that the metabolism of 25-OH-D to 1,25(OH)2D in the kidney is strictly regulated by a feedback system to give a constant level of 1,25(OH)2D in plasma (1) . Our data on the plasma levels of 1,25(OH)2D3 also showed the regulation system because all of the values were approximately constant within the normal range (35-65pg/ml) as shown in Fig. 1 . The results are similar to those reported by Hartwell et al. (14) . The plasma levels of 24,25(OH)2D3 showed only a small change of about 1ng/ml, being within the normal range (1-4ng/ml).
With regard to the changes in the plasma levels of exogenous vitamin D2 andd its metabolites in experiment 1, as shown in Fig. 1 , both the levels of vitamin D2 and 24,25(OH)2D2 remained below the detectable limits during the experiment period, respectively. On the other hand, although the levels of 25-OH-D2 and 1,25(OH)2D2 showed a slight increase and the undetectable levels in the first half of the experiment period, respectively, minor increases in both compounds were observed in the latter half. Therefore, it is suggested that a significant increase in 25-OH-D2 may occur when an experiment with a daily dose of 400IU of vitamin D2 is conducted for a term longer than 1 week (i.e., longer than 6 months). Figure 2 shows the hourly changes in the plasma levels of 25-OH-D and 1,25(OH)2D by the daily oral administration of 400IU of vitamin D2. When the changes were observed at short time intervals after the administration, no special pattern was obtained; more long-term administration in the experiments in thus required. We have already started a long-term experiment with daily oral administration of 400IU of vitamin D2/day for one year and the results will be reported. Figure 3 shows the hourly variation in the plasma levels after a single dose of 4,000IU of vitamin D2. The plasma levels of vitamin D3 and its metabolites were not specifically affected by the administration of vitamin D2, which were within the respective normal ranges. On the other hand, the single dose of vitamin D2 (4,000 IU) effected a significant increase in the plasma levels of vitamin D2 itself although these were not so large. The results suggest that a significant increase of the D2 compounds in plasma may be observed by single dose of 4,000IU of vitamin D2. However, since the administration of vitamin D2 results in the small increase of plasma 25-OH-D2 levels, a single dose of 4,000IU of vitamin D2 may be still insufficient to give positive effects on the plasma levels. The plasma levels of 1,25(OH)2D2 were slightly increased within 24h after the administration, and those of 24,25(OH)2D2 were below the detectable limit. The results also suggest that the single dose may be insufficient to increase the plasma levels of 1,25(OH)2D and 24,25(OH)2D. However, the single dose of 4,000IU of vitamin D2 (which is 40 times higher than the RDA in Japan) may not give a risk of hypervitaminosis D.
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